Search
Now showing items 1-10 of 91
Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants
(Pergamon-Elsevier Science Ltd, 2003-12)
In addition to their well known actions on monoamine reuptake, tricyclic antidepressants have been shown to modulate ligand-gated ion channels (LGICs). Since the muscle nicotinic acetylcholine receptor (AChR) has been the ...
Discovery of Tricyclic Clerodane Diterpenes as Sarco/Endoplasmic Reticulum Ca2+-ATPase Inhibitors and Structure−Activity Relationships
(2015-05-20)
Tricyclic clerodane diterpenes (TCDs) are natural compounds that often show potent cytotoxicity for cancer cells, but their mode of action remains elusive. A computationally based similarity search (CDRUG), combined with ...
The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha(1B)-adrenoceptors
(Pergamon-Elsevier B.V. Ltd, 2010-07-01)
Although it is long known that the tricyclic antidepressants amitriptyline, nortriptyline and imipramine inhibit the noradrenaline transporter and alpha(1)-adrenoceptors with similar affinities, which may lead to self-cancelling ...
A concise route to the azaspirodecane moiety of halichlorine and structurally related alkaloids
(Amer Chemical SocWashingtonEUA, 2005)
Analgésicos Tópicos
(2012-03-01)
Background and objectives: Pain treatment involves the usage of common and opioid analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs) and adjuvant analgesics. Traditionally, these drugs are administered systemically ...
Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders
(2003-07-01)
Temporomandibular disorder (TMD) is characterized by a combination of symptoms affecting the temporomandibular joint and/or chewing muscles. The two most common clinical TMD symptoms are pain and dysfunction. Pain is usually ...
Diels-Alder reactions of 6-substituted 1-(p-nitrobenzoyl)-5,6-dihydro-2-pyridinones
(Georg Thieme Verlag KgStuttgartAlemanha, 2002)
Pharmacogenomics in chronic pain therapy: From disease to treatment and challenges for clinical practice
(2019-01-01)
Pharmacogenomics (PGx) has emerged as an encouraging tool in chronic pain therapy. Genetic variations associated with drug effectiveness or adverse reactions (amitriptyline/nortriptyline/codeine/oxycodone/tramadol-CYP2D6, ...
Synthesis of tricyclic analogs of stephaoxocanidine and their evaluation as acetylcholinesterase inhibitors
(Pergamon-Elsevier Science Ltd., 2005)